Skip to content

Application of intranasal dexmedetomidine combined with sevoflurane inhalation in children with MRI sedation

Application of intranasal dexmedetomidine combined with sevoflurane inhalation in children with MRI sedation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020694
Enrollment
Unknown
Registered
2019-01-13
Start date
2019-02-14
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric MRI sedation

Interventions

Group A:3ug/kg dexmedetomidine intranasal
Group B:dexmedetomidine intranasal 3ug/kg + chloral hydrate 50mg/kg orally
Group C:dexmedetomidine intranasal 3ug/kg + Sevoflurane inhalation
Group D:2.5% sevoflurane inhalation

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: In my medical center, ASA grade I~II, children aged 1 to 6 years old with MRI plain scan. The time required to scan the part is <30min.

Exclusion criteria

Exclusion criteria: Patients with severe heart, liver and kidney disease; a history of drug allergy or surgery contraindications; asthma; neurological diseases; genetic metabolic diseases

Design outcomes

Primary

MeasureTime frame
sucess rate;induce time;recover time;pediatric anesthesia emergence delirium scale;

Secondary

MeasureTime frame
The change of vital signs;Satisfaction score;

Countries

China

Contacts

Public ContactLIU WEI

Children's hospital of Chongqing Medical University

274110368@qq.com+86 15123201847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026